top of page

Trial completion announcement

25 Jul 2023

Afferent Medical Solutions announces a successful completion of its Phase II sham-controlled randomized trial, looking at autonomic modulation by transcutaneous vagal nerve stimulation in acute ischemic stroke patients requiring mechanical thrombectomy

Afferent Medical Solutions announces a successful completion of its Phase II sham-controlled randomized trial, looking at autonomic modulation by transcutaneous vagal nerve stimulation in acute ischemic stroke patients requiring mechanical thrombectomy

bottom of page